Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond

Jeffrey E Gershenwald^{1

2}, Richard A Scolyer^{3

4

5}

Affiliations

¹ Departments of Surgical Oncology and Cancer Biology, Unit 1484, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jgershen@mdanderson.org.
² Melanoma and Skin Center, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jgershen@mdanderson.org.
³ Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
⁴ Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
⁵ Sydney Medical School, The University of Sydney, Sydney, NSW, Australia.

Editorial

Jeffrey E Gershenwald et al. Ann Surg Oncol. 2018 Aug.

. 2018 Aug;25(8):2105-2110.

doi: 10.1245/s10434-018-6513-7. Epub 2018 May 30.

Jeffrey E Gershenwald^{1

2}, Richard A Scolyer^{3

4

5}

¹ Departments of Surgical Oncology and Cancer Biology, Unit 1484, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jgershen@mdanderson.org.
² Melanoma and Skin Center, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jgershen@mdanderson.org.
³ Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
⁴ Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
⁵ Sydney Medical School, The University of Sydney, Sydney, NSW, Australia.

Erratum in

Correction to: Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond.
Gershenwald JE, Scolyer RA. Gershenwald JE, et al. Ann Surg Oncol. 2018 Dec;25(Suppl 3):993-994. doi: 10.1245/s10434-018-6689-x. Ann Surg Oncol. 2018. PMID: 30105437

No abstract available